Baxter signs British flu vaccine deal

Aug 17, 2007

Baxter International said it has entered into an agreement to supply Britain with flu vaccine in the event of a bird flu pandemic.

The Deerfield, Ill., company is in the final stages of testing for a vaccine against H5N1 strains of avian influenza.

Baxter said it will manufacture its pandemic vaccine in a serum-free, vero cell-based system that accelerates vaccine availability. The company said vaccines produced using this process can be released within approximately 12 weeks, significantly earlier than with traditional egg-based systems.

The vero cell culture gives the company the flexibility to quickly respond to emerging variant pandemic virus strains, Baxter said in a news release.

The Chicago Tribune said the advanced supply agreement could be worth tens of millions of dollars to the company over the next four years.

British health officials said they signed more than $300 million in contracts with Baxter and GlaxoSmithKline to supply a vaccine as soon as the strain is identified by the World Health Organization.

Copyright 2007 by United Press International

Explore further: Investigational drug improves sleep disorder among the blind

add to favorites email to friend print save as pdf

Related Stories

Expert panel to view confidential swine flu papers

May 19, 2010

(AP) -- An expert panel investigating the World Health Organization's response to last year's swine flu outbreak said Wednesday it wants to see confidential exchanges between the U.N. body and drug companies.

EU drug agency: License 2 swine flu vaccines

Sep 25, 2009

(AP) -- The European Union's drug regulator recommended Friday that two swine flu vaccines be licensed in the 27-nation bloc to ensure their availability before the start of the normal flu season.

Europe fast-tracking swine flu vaccine

Jul 26, 2009

(AP) -- In a drive to inoculate people against swine flu before winter, many European governments say they will fast-track the testing of a new flu vaccine, arousing concern among some experts about safety ...

Fight for swine flu vaccine could get ugly

Jul 16, 2009

(AP) -- An ugly scramble is brewing over the swine flu vaccine - and when it becomes available, Britain, the United States and other nations could find that the contracts they signed with pharmaceutical companies are easily ...

Recommended for you

Investigational drug improves sleep disorder among the blind

Jun 17, 2013

An investigational new drug significantly improved a common and debilitating circadian rhythm sleep disorder that frequently affects people who are completely blind, a multicenter study finds. The results were presented Monday ...

US: 'Pay to delay' generic drugs can be illegal (Update)

Jun 17, 2013

The Supreme Court ruled Monday that deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can be sometimes be illegal and ...

Medications to prevent clots not reaching some patients

Jun 14, 2013

Researchers at Johns Hopkins report that hospitalized patients do not receive more than one in 10 doses of doctor-ordered blood thinners prescribed to prevent potentially lethal or disabling blood clots, a decision they say ...

User comments : 0

More news stories

Dish won't submit revised bid for Sprint

Satellite TV operator Dish Network Corp. said Tuesday it would not submit a revised bid for Sprint, leaving the path open for the wireless carrier to accept what it already considers a superior offer from Japan's Softbank.

Cape Wind gets $200M investment from Danish fund

The Cape Wind offshore wind project has secured a $200 million investment from a Danish pension fund in what the wind farm's president said Tuesday is a milestone for the long-delayed project.